Takeda Pharmaceutical (TAK) EPS (Basic) Growth (1y) (2018 - 2026)
Takeda Pharmaceutical (TAK) EPS (Basic) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 65.56% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 5.87% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -389.31% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -11.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 105.98% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,385.12% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -15.37% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -257.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -389.31% |
| Dec 31, 2025 | -253.72% |
| Sep 30, 2025 | 3.95% |
| Jun 30, 2025 | 2.97% |
| Mar 31, 2025 | 25.57% |
| Dec 31, 2024 | -3,288.75% |
| Sep 30, 2024 | 1,743.15% |
| Jun 30, 2024 | 536.80% |
| Mar 31, 2024 | -19.73% |
| Dec 31, 2023 | -77.18% |
| Sep 30, 2023 | -27.43% |
| Jun 30, 2023 | -34.61% |
| Mar 31, 2023 | 918.32% |
| Dec 31, 2022 | 26.81% |
| Sep 30, 2022 | 49.48% |
| Jun 30, 2022 | -31.47% |
| Mar 31, 2022 | -105.24% |
| Dec 31, 2021 | -34.85% |
| Sep 30, 2021 | 1,053.64% |
| Jun 30, 2021 | 27.75% |